Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Study on Small Bowel Lesions Suggestive of Crohn's Disease in Patients With Moderate to Severe Plaque Psoriasis Treated With Adalimumab

NCT01556672 is registered in ClinicalTrials.gov with Innovaderm Research Inc. as lead sponsor.

NCT NCT01556672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01556672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Study on Small Bowel Lesions Suggestive of Crohn's Disease in Patients With Moderate to Severe Plaque Psoriasis Treated With Adalimumab
Lead sponsor
Innovaderm Research Inc.
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2012
Completion date
April 30, 2016
Enrollment
100 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, plaque psoriasis